OBINUTUZUMAB ( DrugBank: Obinutuzumab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	5
222	一次性ネフローゼ症候群	6

49. 全身性エリテマトーデス

臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04702256 (ClinicalTrials.gov)	December 9, 2021	30/11/2020	Induction Therapy for Lupus Nephritis With no Added Oral Steroids: An Open Label Randomised Multicen ...	Induction Therapy for Lupus Nephritis With no Added Oral Steroids: An Open Label Randomised Multicen ...	Lupus Nephritis;Systemic Lupus Erythematosus (SLE)	Drug: Obinutuzumabadministration;Drug: Administration of Methylprednisolone + Prednisone + Mycopheno ...	Assistance Publique - Hôpitaux de Paris	Roche Pharma AG	Recruiting	14 Years	N/A	All	196	Phase 3	France
2	NCT04963296 (ClinicalTrials.gov)	October 26, 2021	7/7/2021	A Study to Evaluate the Efficacy and Safety of Obinutuzumabin Participants With Systemic Lupus Eryth ...	A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficac ...	Systemic Lupus Erythematosus	Drug: Obinutuzumab;Drug: Placebo;Drug: Acetaminophen/Paracetamol;Drug: Diphenhydramine hydrochloride ...	Hoffmann-La Roche	NULL	Recruiting	18 Years	75 Years	All	200	Phase 3	United States;Argentina;France;Italy;Mexico;New Zealand;Peru;Russian Federation;South Africa;Spain;B ...
3	EUCTR2020-005760-57-PL (EUCTR)	25/10/2021	21/09/2021	A Study to Evaluate the Efficacy and Safety of Obinutuzumabin Patients with Systemic Lupus Erythemat ...	A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICAC ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Trade Name: Gazyvaro INN or Proposed INN: OBINUTUZUMAB	F. Hoffmann-La Roche Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Mexico;Argentina;Poland;Brazil;Au ...
4	EUCTR2020-005760-57-IT (EUCTR)	09/09/2021	12/10/2021	A Study to Evaluate the Efficacy and Safety of Obinutuzumabin Patients with Systemic Lupus Erythemat ...	A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICAC ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Trade Name: Gazyvaro Product Name: Gazyvaro Product Code: [na] INN or Proposed INN: OBINUTUZUMAB	F. HOFFMANN - LA ROCHE LTD.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Mexico;Argentina;Brazil;Poland;Au ...
5	EUCTR2020-005760-57-ES (EUCTR)	30/07/2021	23/06/2021	A Study to Evaluate the Efficacy and Safety of Obinutuzumabin Patients with Systemic Lupus Erythemat ...	A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICAC ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Trade Name: Gazyvaro INN or Proposed INN: OBINUTUZUMAB	Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La R ...	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Mexico;Argentina;Brazil;Poland;Au ...

First Previous1Next Last

先頭へ

222. 一次性ネフローゼ症候群

臨床試験数 : 285 / 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05050214 (ClinicalTrials.gov)	March 2022	9/9/2021	Obinutuzumab in Primary MN	Obinutuzumabfor Primary Membranous Nephropathy: a Pilot Study in Patients With Rituximab-resistant o ...	Membranous Nephropathy	Drug: Obinutuzumab	Mario Negri Institute for Pharmacological Research	Roche S.p.a	Not yet recruiting	18 Years	N/A	All	20	Phase 2	Italy
2	EUCTR2021-004864-81-IT (EUCTR)	17/12/2021	17/09/2021	Proposta di studio per valutare l’efficacia di Obinutuzumab, un anticorpo anti-CD20, in pazienti con ...	Proposta di studio per valutare l’efficacia di Obinutuzumab, un anticorpo anti-CD20, in pazienti con ...	PRIMARY MEMBRANOUS NEPHROPATHY MedDRA version: 21.1;Level: LLT;Classification code 10027170;Term: Me ...	Trade Name: GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCI ...	IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 2	Italy
3	NCT04983888 (ClinicalTrials.gov)	November 17, 2021	21/7/2021	Obinutuzumab in Primary FSGS	A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMABin Treat ...	Primary Focal Segmental Glomerulosclerosis	Drug: Obinutuzumab	Mayo Clinic	Genentech, Inc.	Recruiting	18 Years	N/A	All	12	Phase 2	United States
4	NCT04629248 (ClinicalTrials.gov)	June 25, 2021	27/10/2020	A Study Evaluating the Efficacy and Safety of Obinutuzumabin Participants With Primary Membranous Ne ...	A Phase III Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Effica ...	Primary Membranous Nephropathy	Drug: Obinutuzumab;Drug: Tacrolimus;Drug: Methylprednisolone;Drug: Acetaminophen;Drug: Diphenhydrami ...	Hoffmann-La Roche	NULL	Recruiting	18 Years	75 Years	All	140	Phase 3	United States;Argentina;Brazil;China;France;Israel;Italy;Poland;Russian Federation;Spain;Turkey;Ukra ...
5	EUCTR2020-003233-38-PL (EUCTR)	13/04/2021	24/02/2021	A Study to Evaluate Efficacy and Safety of Obinutuzumabin Patients with Primary Membranous Nephropat ...	A PHASE III, RANDOMIZED, OPEN-LABEL ACTIVE COMPARATOR-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFIC ...	Primary Membranous Nephropathy (pMN) MedDRA version: 21.1;Level: LLT;Classification code 10027170;Te ...	Trade Name: Gazyvaro Product Name: Obinutuzumab Product Code: RO5072759 INN or Proposed INN: OBINUTUZUM ...	F.Hoffmann-La Roche Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	140	Phase 3	United States;Spain;Ukraine;Turkey;Israel;Russian Federation;Italy;France;Canada;Argentina;Poland;Br ...
6	EUCTR2020-003233-38-IT (EUCTR)	06/04/2021	04/06/2021	A Study to Evaluate Efficacy and Safety of Obinutuzumabin Patients with Primary Membranous Nephropat ...	A PHASE III, RANDOMIZED, OPEN-LABEL ACTIVE COMPARATOR-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFIC ...	Primary Membranous Nephropathy (pMN) MedDRA version: 21.1;Level: LLT;Classification code 10027170;Te ...	Trade Name: Gazyvaro Product Name: Obinutuzumab Product Code: [RO5072759] INN or Proposed INN: OBINUTUZ ...	F. HOFFMANN - LA ROCHE LTD.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	140	Phase 3	United States;Spain;Ukraine;Turkey;Israel;Russian Federation;Italy;France;Canada;Argentina;Brazil;Po ...

First Previous1Next Last

先頭へ